Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência.

September 14, 2020September 14, 2020

Brensocatib Significantly Lowers Flare Risk in Non-CF Bronchiectasis, Trial Shows

News

Treatment with brensocatib significantly and safely extended the time to a first exacerbation and lowered flare rates in people with non-cystic fibrosis bronchiectasis (NCFBE), results from a Phase 2 trial ... Read more

September 11, 2020September 11, 2020

Bronchiectasis Aggravates Asthma Outcomes, Review Study Finds

News

People with asthma who also have bronchiectasis are at greater risk of severe disease and exacerbations, and more likely to be admitted to the hospital, compared with patients without ... Read more

July 10, 2020July 10, 2020

Causes, Symptoms of Non-CF Bronchiectasis Have Changed in Children, Study Suggests

News

Children diagnosed with non-cystic fibrosis bronchiectasis since 2002 have better lung function at diagnosis, distinct disease causes, and higher frequency of sputum infections, compared to children followed in the ... Read more

June 22, 2020June 22, 2020

Progenitor Cell Transplant May Safely Stop Progression in Bronchiectasis

News

Transplanting progenitor cells to the lungs of bronchiectasis patients is safe and appears to stabilize disease, with no worsening in lung and physical function for at least 48 weeks, ... Read more

May 11, 2020December 11, 2020

Savara to Advance Bronchiectasis Therapy Apulmiq After Deal With Grifols

News

Savara Pharmaceuticals has acquired global rights to develop and commercialize Grifols‘ inhaled antibiotic formulation Apulmiq (ciprofloxacin) for the treatment for non-cystic fibrosis bronchiectasis (NCFB). The agreement comes a couple ... Read more

April 20, 2020April 20, 2020

NTMir Opens Website to Educate Patients About Bronchiectasis, NTM

News

The nonprofit NTM Info & Research (NTMir) has launched a companion website that provides extensive insight into bronchiectasis and related infections, empowering people with the condition to participate in ... Read more

August 23, 2016August 23, 2016

Bronchiectasis Mortality, Clinical Outcomes More Accurately Predicted with BSI

News

Bronchiectasis Severity Index (BSI) and FACED are prediction tools that can provide clinically relevant evaluations of bronchiectasis severity, mortality and several other outcomes that may influence clinical decision-making processes ... Read more

August 16, 2016August 17, 2016

Gene Mutation FUT2 Influential in Non-Cystic Fibrosis Bronchiectasis

News

Patients with non-cystic fibrosis bronchiectasis have better outcomes when they have particular mutations in both copies of the FUT2 gene, according to researchers at the South Australian Health and ... Read more

August 9, 2016August 9, 2016

Antireflux Therapy May Help Obese Bronchiectasis Patients with GERD

News

Obese bronchiectasis patients with gastroesophageal reflux disease (GERD) may benefit from antireflux proton pump inhibitors according to researchers at the Seoul National University Bundang Hospital, in Korea. The study “Effect of ... Read more

August 4, 2016August 4, 2016

Study Identifies 3 Key Risk Factors for Bronchiectasis in COPD Patients

News

Male gender, a history of tuberculosis, and high levels of serum total immunoglobulin E (T-IgE) are all risk factors for bronchiectasis in COPD patients, researchers at Beijing Tongren Hospital and ... Read more